The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey
May 1, 2014, 00:00
10.1016/j.jval.2014.03.672
https://www.valueinhealthjournal.com/article/S1098-3015(14)00723-2/fulltext
Title :
The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00723-2&doi=10.1016/j.jval.2014.03.672
First page :
A115
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
104